Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Cytomx Thera (CTMX)

Cytomx Thera (CTMX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of CytomX Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 20, 2020 - CTMX

New York, New York--(Newsfile Corp. - May 25, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:

CTMX : 9.28 (-1.43%)
SHAREHOLDER ALERT: ANAB HALL CTMX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

NEW YORK, NY / ACCESSWIRE / May 25, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss...

ANAB : 19.87 (+2.32%)
HALL : 2.63 (-2.95%)
CTMX : 9.28 (-1.43%)
CLASS ACTION UPDATE for CONN, R and CTMX: Levi and Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / May 25, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested...

CONN : 6.28 (+0.96%)
R : 31.10 (-0.73%)
CTMX : 9.28 (-1.43%)
SHAREHOLDER ALERT: CONN R CTMX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

NEW YORK, NY / ACCESSWIRE / May 24, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss...

CONN : 6.28 (+0.96%)
R : 31.10 (-0.73%)
CTMX : 9.28 (-1.43%)
CytomX Therapeutics Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In CytomX Therapeutics, Inc. To Contact The Firm

New York, New York--(Newsfile Corp. - May 23, 2020) -  Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in CytomX Therapeutics, Inc. (NASDAQ: CTMX) ("CytomX" or the "Company")...

CTMX : 9.28 (-1.43%)
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SERV, BIDU and CTMX

NEW YORK, NY / ACCESSWIRE / May 22, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate...

SERV : 29.13 (-0.27%)
BIDU : 103.32 (-6.10%)
CTMX : 9.28 (-1.43%)
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In CytomX Therapeutics, Inc. To Contact The Firm

New York, New York--(Newsfile Corp. - May 22, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in CytomX Therapeutics, Inc. (NASDAQ: CTMX) ("CytomX" or the "Company")...

CTMX : 9.28 (-1.43%)
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of DOYU, HAFC and CTMX

NEW YORK, NY / ACCESSWIRE / May 22, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders...

DOYU : 6.91 (-9.20%)
HAFC : 8.69 (-1.14%)
CTMX : 9.28 (-1.43%)
CYTOMX LOSS ALERT, ROSEN, A TOP RANKED INVESTOR FIRM, Announces Filing of Securities Class Action Lawsuit Against CytomX Therapeutics, Inc.; Encourages Investors with Losses in Excess of $100K to Contact the Firm - CTMX

, /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of CytomX Therapeutics, Inc. (NASDAQ: CTMX)...

CTMX : 9.28 (-1.43%)
CTMX Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against CytomX Therapeutics, Inc. and Encourages Investors to Contact the Firm

, /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against CytomX Therapeutics, Inc. ("CytomX" or "the Company")...

CTMX : 9.28 (-1.43%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of CytomX Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 20, 2020 - CTMX

New York, New York--(Newsfile Corp. - May 22, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:

CTMX : 9.28 (-1.43%)
CYTOMX THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against CytomX Therapeutics, Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that a class action lawsuit has been filed in the United States District Court for the Northern District of California...

CTMX : 9.28 (-1.43%)
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against CytomX Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against CytomX Therapeutics, Inc. ("CytomX" or "the Company") (NASDAQ: CTMX) for violations...

CTMX : 9.28 (-1.43%)
EQUITY ALERT: ROSEN, NATIONAL TRIAL LAWYERS, Announces Filing of Securities Class Action Lawsuit Against CytomX Therapeutics, Inc. - CTMX

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of CytomX Therapeutics, Inc. (NASDAQ: CTMX) between May 17, 2018,...

CTMX : 9.28 (-1.43%)
Pomerantz Law Firm Announces the Filing of a Class Action against CytomX Therapeutics Inc. and Certain Officers - CTMX

Pomerantz LLP announces that a class action lawsuit has been filed against CytomX Therapeutics Inc. ("CytomX" or the "Company") (NASDAQ: CTMX) and certain of its officers. The class action, filed in United...

CTMX : 9.28 (-1.43%)
Watch for Cytomx Therapeut to Potentially Rebound After Falling 3.47% Yesterday

Cytomx Therapeut (NASDAQ:CTMX) traded in a range yesterday that spanned from a low of $8.66 to a high of $9.33. Yesterday, the shares fell 3.5%, which took the trading range below the 3-day low of $8.95...

CTMX : 9.28 (-1.43%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CytomX Therapeutics, Inc. - CTMX

Pomerantz LLP is investigating claims on behalf of investors of CytomX Therapeutics, Inc. ("CytomX" or the "Company") (NASDAQ: CTMX). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com...

CTMX : 9.28 (-1.43%)
CytomX Therapeutics Announces Details of Presentations at the American Society of Clinical Oncology ASCO20 Virtual Scientific Program

CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on its Probody(R) therapeutic...

CTMX : 9.28 (-1.43%)
CytomX Therapeutics Announces First Quarter 2020 Financial Results and Provides Business Update

CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on its Probody(R) therapeutic...

CTMX : 9.28 (-1.43%)
All You Need to Know About CytomX Therapeutics (CTMX) Rating Upgrade to Strong Buy

CytomX Therapeutics (CTMX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

CTMX : 9.28 (-1.43%)

Van Meerten Stock Picks

My 5 Favorite Mid Caps
Summary 100% technical buy signals with current momentum.
CRUS +0.19 , SEDG -6.12 , THC -0.17 , TER +1.01 , LITE +1.84
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar